Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. - Wikidata - wikimedia - TriplyDB

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

http://www.wikidata.org/entity/Q44117626

about

Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adults Interventions for treating AIDS-associated Hodgkin´s Lymphoma in treatment-naive adults with AIDS Non-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART era The rising challenge of non-AIDS-defining cancers in HIV-infected patients The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy.Blood and marrow transplant for lymphoma patients with HIV/AIDS.Hodgkin's Disease in Patients with HIV Infection EBV and HIV-Related Lymphoma Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging Problem Treatment options of AIDS-related lymphoma.Should HIV-positive patients with lymphoma be offered stem cell transplants?Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.Antitumour effects of antiretroviral therapy.Evolving spectrum and incidence of non-AIDS-defining malignancies.HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.Stem cell transplantation for lymphoma patients with HIV infection.Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.Hodgkin lymphoma in patients with HIV infection: a review.Diagnosis and management of lymphomas and other cancers in HIV-infected patients.Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).Decision-making in the management of adult classical Hodgkin's lymphoma: determining the optimal treatment.Hodgkin lymphoma in the elderly, pregnant, and HIV-infected.Ongoing change in the treatment of HIV-associated malignancies in the HAART era.HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud Managing HIV and Hodgkin lymphoma in the twenty-first century.Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen.Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin's disease.Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan.Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease.Intracerebral progression of Hodgkin lymphoma in a man with HIV.HIV-related lymphoma

P2860

Q24245321-860ECDBE-423D-4E83-9784-885A86354860 Q24245877-1F57382C-DBA1-477D-A2BC-39BB6CC895D6 Q26797897-3C2E2471-4B0C-4288-B282-5C418BCF55E2 Q26861496-5039ADA6-465E-4421-BCD1-50296E1D113E Q26991549-FB3517D3-27DC-4769-A9F8-3416DFA7CAF8 Q30244166-EFC5CD15-CC94-4FB3-B6AC-98EF2BEFC183 Q34068528-3807707E-2BCD-435F-B006-1EF964301408 Q34169941-B0BD81F3-9116-40AB-8FAE-9DE51A7A475D Q34549450-EDA0B7AB-59E4-4AF3-BF06-E52893BDA7B1 Q34571564-6417E4D1-137B-472F-AE24-C1647D954E5E Q35183751-1B452094-F71F-4C6B-9C66-F43466CEA2E6 Q35547755-AC69C868-ED85-4F1A-9DF9-3A5787FA6FBA Q35915648-C32D30ED-EB68-4DF0-BE18-EE44AD643919 Q35934144-A709C0A2-6810-4C70-B137-42E7FEFE37C5 Q37353390-55429D43-FE80-443A-92B7-CF5F1BB40BF0 Q37658727-527B0351-C4DC-49AA-BE06-6599273F6D41 Q37793405-83178F6D-CA57-4024-8740-8FC22ACF92C2 Q37832198-41D89E4A-E701-4E75-B104-190B240A3DB9 Q38006636-BEA1943E-5C8E-4E89-9C80-316A1F084C0A Q38194845-6BD07F82-7A7F-4D08-8DFE-2826B873ABDB Q38210131-6B53F688-91AC-45FF-96C2-63428D1F9D29 Q38337152-4262618E-B52C-4D02-BC5A-F6866655301D Q38920105-F255C33C-61ED-41C7-962C-355797298A1F Q39207881-4999099C-270F-4910-A684-46F238CC1DAD Q40512007-E7B6B266-BEAF-4982-B1A1-4381B531E9FF Q40702849-88E2056F-4300-48DB-B2B3-FF9EA93D0D86 Q41728053-235DC4D0-5486-46CE-8963-5FE5C273A483 Q42213911-7D51E2CC-965D-452D-82E5-B39306D5CCFA Q43065877-F1780189-E88A-4414-8E20-998E00D57C78 Q43276004-08DD02DA-44F8-4A0B-8E19-7ACABFE45A46 Q45172725-82456552-86D6-4392-AFB5-0DEA847E813D Q45356450-F40CBF31-0F38-4A31-8848-CBB7717F78B3 Q45640458-DE9B293E-C719-4BAA-8E5B-DD9D0DA35B6E Q48398047-A9179DA3-0872-4197-B34F-4C968AE3DA7A Q56112360-17EF7FC6-BE0A-455E-B6ED-60056C1C2ED4

P2860

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

http://www.wikidata.org/entity/Q44117626

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Stanford V regimen and concomi ...... kin disease and HIV infection.

@en

Stanford V regimen and concomi ...... kin disease and HIV infection.

@nl

type

label

Stanford V regimen and concomi ...... kin disease and HIV infection.

@en

Stanford V regimen and concomi ...... kin disease and HIV infection.

@nl

prefLabel

Stanford V regimen and concomi ...... kin disease and HIV infection.

@en

Stanford V regimen and concomi ...... kin disease and HIV infection.

@nl

P1433

Q44117626-F92ADFBD-E49B-41D8-950E-7F557CA0FAFC

P1476

Q44117626-988F5DF9-2E5C-4BDF-9553-84B3B1BCB480

P2093

Q44117626-0CD8229B-B15C-48A9-90A5-A6D89425DF2F

Q44117626-1AA60B51-2D5F-48BF-977C-72D346A65E69

Q44117626-203E42F0-0AE4-402E-B5B8-8A7C08287458

Q44117626-4DFE2175-16F2-4684-8D81-DE79E30696B8

Q44117626-831CCA82-FAB9-4208-BE09-E69EC7507C34

Q44117626-D19D400D-2C21-4116-B1B8-4C0E69AAF4BF

Q44117626-D2CAA87B-CB05-455A-8977-740607FEA7B8

Q44117626-E5FD387B-8FDC-49E7-9191-28AAD548D495

Q44117626-ECB8AA63-3276-429E-AF8F-8C2BCB69A426

Q44117626-ECEE159F-94D6-4C5E-9C63-FFF40C833260

P304

Q44117626-1E46B11E-67D2-42CC-8404-7647041D946C

P31

Q44117626-892BFCD6-A685-4890-8CFB-29A11551423B

P356

Q44117626-53D0F57B-9635-40BC-98F8-3541AA6C3CC9

P407

Q44117626-997EE437-914D-4364-A06C-6FDFDC493243

P433

Q44117626-DAC0F312-7491-4601-9FAC-D290E2B4E97C

P478

Q44117626-8035B6E5-2875-41E0-B309-6FABA932D850

P50

Q44117626-BE0BA340-4552-4CB6-8FD2-95BE9B1A517D

Q44117626-CC21B66F-08AA-4A22-A195-BD59E614F0CE

P577

Q44117626-55F662E6-DFCD-496A-8594-B80FAFC8BACF

P5875

Q44117626-7BBB3220-0E5B-4157-956C-F64FDD366A8A

P698

Q44117626-C9BC1F65-2F86-4118-BB89-1A3BCCDA43C2

P356

BLOOD-2002-03-0989

P1433

P1476

Stanford V regimen and concomi ...... gkin disease and HIV infection

@en

P2093

Andrea Antinori

http://www.w3.org/2001/XMLSchema#string

Clara Schiantarelli

http://www.w3.org/2001/XMLSchema#string

Emanuela Vaccher

http://www.w3.org/2001/XMLSchema#string

Ezio Nigra

http://www.w3.org/2001/XMLSchema#string

Giampiero di Gennaro

http://www.w3.org/2001/XMLSchema#string

Giuseppe Rossi

http://www.w3.org/2001/XMLSchema#string

Jean Gabarre

http://www.w3.org/2001/XMLSchema#string

Marco Fasan

http://www.w3.org/2001/XMLSchema#string

Maurizio Mena

http://www.w3.org/2001/XMLSchema#string

Renato Talamini

http://www.w3.org/2001/XMLSchema#string

P304

1984-1988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-03-0989

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11188781

http://www.w3.org/2001/XMLSchema#string

P698

12200356

http://www.w3.org/2001/XMLSchema#string